Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Mar;71(3):405–409.

Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.

L G Filion 1, R Saginur 1, N Szczerbak 1
PMCID: PMC1541666  PMID: 2968200

Abstract

The kinetics of the cellular and humoral responses of 30 recipients of hepatitis B vaccine were studied. All individuals exerted an HBsAg blastogenic response sometime throughout the study period but the maximum response was detected on day 28 and 56. The removal of CD8+ cells enhanced significantly the HBsAg response at the times tested, whereas treatment with anti-CD4, anti-CD8, C' and anti-CD4+ C' had no effect. Vaccination also led to the depression of phytohaemagglutinin (PHA) blastogenic response. This response was maximally suppressed 4 to 8 days after immunization at least for the primary and secondary responses and 28 days after the third dose of vaccine. The humoral response to HBsAg was detected only after the second dose of vaccine was given. The results suggest that a CD8+ cell controls the magnitude and intensity of the HBsAg blastogenic response, which may help to explain why several investigators had not been able to detect this response in hyperimmunized individuals. Primary immunization with HBsAg does lead to an expansion of B memory since a secondary response anti-HBsAg was observed.

Full text

PDF
405

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnaba V., Levrero M., Van Dyke A. D., Musca A., Cordova C., Balsano F. T-cell subsets in the hyporesponsiveness to hepatitis B surface antigen (HBsAg) and antigen-specific suppressor lymphocytes in chronic hepatitis B virus (HBV) infection. Clin Immunol Immunopathol. 1985 Mar;34(3):284–295. doi: 10.1016/0090-1229(85)90177-1. [DOI] [PubMed] [Google Scholar]
  2. Barnaba V., Musca A., Cordova C., Levrero M., Ruocco G., Albertini-Petroni V., Balsano F. Relationship between T cell subsets and suppressor cell activity in chronic hepatitis B virus (HBV) infection. Clin Exp Immunol. 1983 Aug;53(2):281–288. [PMC free article] [PubMed] [Google Scholar]
  3. Chang T. W., Celis E., Miller R. W., Zurawski V. R., Jr, Kung P. C. In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology. 1984 Sep-Oct;4(5):824–829. doi: 10.1002/hep.1840040504. [DOI] [PubMed] [Google Scholar]
  4. Chisari F. V., Castle K. L., Xavier C., Anderson D. S. Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness. J Immunol. 1981 Jan;126(1):38–44. [PubMed] [Google Scholar]
  5. Couch R. B. The effects of influenza on host defenses. J Infect Dis. 1981 Sep;144(3):284–291. doi: 10.1093/infdis/144.3.284. [DOI] [PubMed] [Google Scholar]
  6. Hanson R. G., Hoofnagle J. H., Minuk G. Y., Purcell R. H., Gerin J. L. Cell-mediated immunity to hepatitis B surface antigen in man. Clin Exp Immunol. 1984 Aug;57(2):257–264. [PMC free article] [PubMed] [Google Scholar]
  7. Reinherz E. L., Morimoto C., Fitzgerald K. A., Hussey R. E., Daley J. F., Schlossman S. F. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations. J Immunol. 1982 Jan;128(1):463–468. [PubMed] [Google Scholar]
  8. Reinherz E. L., Rubinstein A., Geha R. S., Strelkauskas A. J., Rosen F. S., Schlossman S. F. Abnormalities of immunoregulatory T cells in disorders of immune function. N Engl J Med. 1979 Nov 8;301(19):1018–1022. doi: 10.1056/NEJM197911083011902. [DOI] [PubMed] [Google Scholar]
  9. Szmuness W., Stevens C. E., Harley E. J., Zang E. A., Oleszko W. R., William D. C., Sadovsky R., Morrison J. M., Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980 Oct 9;303(15):833–841. doi: 10.1056/NEJM198010093031501. [DOI] [PubMed] [Google Scholar]
  10. Thomas H. C., Brown D., Routhier G., Janossy G., Kung P. C., Goldstein G., Sherlock S. Inducer and suppressor T-cells in hepatitis B virus-induced liver disease. Hepatology. 1982 Mar-Apr;2(2):202–204. doi: 10.1002/hep.1840020203. [DOI] [PubMed] [Google Scholar]
  11. Tremolada F., Fattovich G., Panebianco G., Ongaro G., Realdi G. Suppressor cell activity in viral and non-viral chronic active hepatitis. Clin Exp Immunol. 1980 Apr;40(1):89–95. [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES